Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00887432 · ClinicalTrials.gov registry record · NA
Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
A NA study of Prostate Adenocarcinoma, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT00887432 is a NA study of Prostate Adenocarcinoma that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 132 participants, below the 217-participant average among 99 other Prostate Adenocarcinoma trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00887432, a NA study of Prostate Adenocarcinoma, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial studies how well cholecalciferol supplement works in treating patients with localized prostate cancer undergoing observation. Cholecalciferol may help prostate cancer cells become more like normal cells, and to grow and spread more slowly.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Cholecalciferol
- OTHER Quality-of-Life Assessment
- OTHER Laboratory Biomarker Analysis
- DRUG Placebo Administration
- OTHER Patient Observation
Study Locations (1)
New York
- Roswell Park Cancer Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2009-04-08 |
| Est. Completion | 2020-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00887432
The ClinicalTrials.gov registry entry for NCT00887432 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 217-participant average among 99 other Prostate Adenocarcinoma trials with a reported enrollment target (39% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Adenocarcinoma appearing as the primary indexed condition, and to 5 interventions - of which Cholecalciferol is the first listed.
NCT00887432 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00887432 about?
NCT00887432 is a clinical study titled "Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation". This randomized clinical trial studies how well cholecalciferol supplement works in treating patients with localized prostate cancer undergoing observation. Cholecalciferol may help prostate cancer cells become more like normal cells, and to grow and spread more slowly.
What is the current status of trial NCT00887432?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2009-04-08. Estimated completion is 2020-06-08.
What conditions does trial NCT00887432 study?
This clinical trial studies the following conditions: Prostate Adenocarcinoma.
What interventions are being tested in trial NCT00887432?
The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), Quality-of-Life Assessment (OTHER), Laboratory Biomarker Analysis (OTHER), Placebo Administration (DRUG), Patient Observation (OTHER).
Who is sponsoring clinical trial NCT00887432?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00887432 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
RECRUITING · NA
-
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
RECRUITING · NA
-
The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction
RECRUITING · NA
-
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
RECRUITING · NA
-
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
RECRUITING · NA
-
Two-fraction HDR Monotherapy for Localized Prostate Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.